Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Australia's Biosimilar Substitution Policy Under Fire As Etanercept Product Is 'A'-Flagged

Aug 22 2016

• By Ian Schofield

Pharmacist

Related Content

Inflectra to be first 'substitutable' biosimilar in Australia

Aug 21 2015

Australian Survey Reveals Biosimilar Awareness, Switching Concerns

Jun 15 2016

Related Companies

Hospira, Inc.

Johnson & Johnson

Eli Lilly and Company

Sanofi

Merck KGaA

Additional Topics

Australia Asia Pacific Biosimilars Reimbursement Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window